UNSPSC 51372400: Controlled substance analgesic propionates

Controlled substance analgesic drugs made from derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure.

UNSPSC 51372400 Controlled substance analgesic propionates is a Class code covering pharmaceutical products including naloxone, generic multi-source medications, and over-the-counter compounds procured by state and local health agencies, departments of administration, and public health bodies for distribution through authorized wholesalers and direct delivery to community health facilities. State and local governments are buying naloxone and drug deactivation systems for opioid response programs, generic pharmaceuticals through cooperative purchasing vehicles, and exploring direct-to-manufacturer prescription fulfillment models to improve cost management and supply chain efficiency. Issuing bodies span state health and human services commissions, county health departments, cooperative purchasing alliances, and state procurement offices administering multistate contracts. Recent activity shows state health agencies and cooperative purchasing organizations driving the bulk of solicitation activity rather than individual municipalities or school districts.

Recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs and vendor capabilities for a proposed Therapeutic Pharmacy Initiative; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota and Oregon through three authorized wholesalers. Geographic activity centers on Florida, Texas, and Minnesota with multistate cooperative purchasing serving Oregon and other participant jurisdictions. Vendors typically must comply with FDA requirements, maintain cGMP and Drug Supply Chain Security Act certification, hold specified insurance coverage, and commit to EDI capability and transparent pricing models; competitive scoring favors price competitiveness alongside administrative compliance and product availability timelines.